|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01515345 |
|
Date of registration:
|
18/01/2012 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
IDEAL-PCI |
|
Scientific title:
|
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry |
|
Date of first enrolment:
|
July 2011 |
|
Target sample size:
|
1008 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01515345 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Austria
| | | | | | | |
|
Contacts
|
|
Name:
|
Guenter Christ, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kaiser Franz Josef Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- all consecutive PCI patients with stent implantation of our institution
Exclusion Criteria:
- pregnancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Platelet Inhibition
|
|
Coronary Stent Implantation
|
|
Intervention(s)
|
|
Drug: Clopidogrel
|
|
Drug: prasugrel or ticagrelor
|
|
Primary Outcome(s)
|
|
Any Bleeding Event
[Time Frame: 30days]
|
|
Definite Stent Thrombosis
[Time Frame: 30 days]
|
|
Secondary Outcome(s)
|
|
Probable Stent Thrombosis
[Time Frame: 30days]
|
|
Secondary ID(s)
|
|
IDEAL-PCI protocol 1.0
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|